AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05753306 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo stool and blood sample collection
Study NCT06232655 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: A medication used to treat adults with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or acute myeloid leukemia (AML).
Study NCT05753306 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Given via HIPEC
Study NCT06232655 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Medication used for the treatment of myelodysplastic syndrome, myeloid leukemia, and juvenile myelomonocytic leukemia. It is a chemical analog of cytidine, a nucleoside in DNA and RNA.. Azacitidine and its deoxy derivative, decitabine were first synthesized in Czechoslovakia as potential chemotherapeutic agents for cancer.
Study NCT05423093 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Single-Session Virtual Group Psychoeducational Session about Postpartum Depression
Description: Session contents include (1) Introduction to clinic staff, contacts, and resources (2) A video-recorded testimonial of a patient with a history of perinatal depression followed by a group discussion about/reflection on the video; (3) Review of prevalence and signs of PPD; (4) Discussion of clinic PPD screening procedures and rationale for screening; (5) Discussion of self-care and mood monitoring; (6) Discussion of relevant local resources, including information about availability of primary care resources for parents (including uninsured parents) and information about resources addressing social needs.
Study NCT06375369 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Digital health pathway for children with medical complexity requiring tracheostomy (DECIDE-T)
Description: The intervention involves developing a standardized clinical pathway for these children requiring tracheostomy. The pathway comprises of a hospital to home directive, incorporating digital health solutions to support family, caregivers, and healthcare professionals. These digital supports include but are not limited to a Connect Care pathway, resources to aid families to make informed choices during the clinical decision-making process, education modules and high-fidelity simulations to enhance family/caregiver education, an online parental resource center and access to peer support (spanning from hospital to community) and a telehealth post discharge program.
Study NCT06038136 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Decreased Neuro Checks overnight
Description: If a patient is randomized to the intervention group, the team will discontinue neuro-checks between 8pm and 4am. They will otherwise receive the same care, including overnight vital signs. If the patient has a neurologic or hemodynamic change, the primary team may elect to restart the overnight neuro-checks.
Study NCT05255952 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Description: Electrical stimulation of the cardiac plexus
Study NCT04124029 — intervention group
Intervention type: DEVICE
Intervention: No Intervention is used for this study but all subjects will be asked to complete EEG testing and an MRI scan.
Description: No intervention will be used.
Study NCT05753306 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT scan or PET/CT
Study NCT05753306 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: Given via HIPEC
Study NCT05753306 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Gastrectomy
Description: Undergo robotic gastrectomy
Study NCT05753306 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyperthermic Intraperitoneal Chemotherapy
Description: Undergo HIPEC
Study NCT05753306 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT05753306 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PE/CT
Study NCT05753306 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Complete questionnaire
Study NCT06406881 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: physical therapy
Description: Ocular muscle exercise which is consist of three exercise like palm exercise, blinking exercise, pencil pushup exercise.~3 sets of 10 repetition 5 days a week. As well as strengthening exercise the neck isometric exercise. each exercise consist of 3 sets of 5 repetition 5 days a week.~Total of three sessions .
Study NCT06406881 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: physical therapy
Description: Ocular muscle exercise which is consist of three exercise like palm exercise, blinking exercise, pencil pushup exercise.~3 sets of 10 repetition 5 days a week. As well as strengthening exercise the neck isometric exercise. each exercise consist of 3 sets of 5 repetition 5 days a week.~Total of three sessions .
Study NCT06406881 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: myofascial release therapy
Description: Experimental group given MFR along with neck isometric and ocular muscle exercise.~myofascial release technique on sternocleidomastoid muscle and upper trapezius muscles. Patients will be treated 3 seconds to 2 minutes, three days in a week.~Ocular muscle exercise will perform 3 sets of 10 repetition 5 days a week. As well as strengthening exercise the neck isometric exercise. This exercise will performed 3 sets of 5 repetition 5 days a week.~Total of three sessions .
Study NCT06389942 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 9MW3011
Description: Single dose intravenously on day 1
Study NCT06389942 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 9MW3011 placebo
Description: Single dose intravenously on day 1
Study NCT04770935 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: efanesoctocog alfa (BIVV001)
Description: Pharmaceutical form:solution for injection Route of administration: intravenous injection
Study NCT05795946 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Whole food-based B and D vitamins
Description: Looking at whole food-based B and D vitamins to reduce TMAO levels and if this can modulate gut diversity
Study NCT05737095 — intervention group
Intervention type: PROCEDURE
Intervention: Pulmonary ultrasound
Description: Within 6 hours of admission to Neonatal Pediatrics and Intensive Care
Study NCT06121596 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breathing Exercise
Description: A breathing exercise is a relaxation technique (or therapy) to increase relaxation (induces a relaxation response) and decrease stress (reduces a stress response).
Study NCT05737238 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention during phase B: Compensatory brain game supporting Goal Management Training intervention
Description: The investigational treatment is only given during the intervention phase (phase B), and consists of six treatment sessions. In the treatment sessions, patients learn and apply the GMT algorithm. This means that the multiple steps of the GMT as well as the actual performance of the IADL-task goals will be learned under guidance of a therapist. In order to facilitate generalization, patients will learn to use the algorithm during the performance of untrained tasks by playing the treatment supporting Plan Game. Because of this, patients are able to practice the application of the GMT algorithm independently at their own home. Besides, the intervention also includes a Plan Tool. This is a mobile application that can be used as an aid during the performance of (instrumental) activities of daily living (IADL) tasks in order to perform activities more independently. The GMT treatment sessions are given twice a week (max. 60 minutes for each attendance).
Study NCT04970771 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Solving Wellness platform
Description: Interactive wellness resources available include a wide range of curated content and resources including fitness and yoga classes, cooking classes, webinars on sleep and various mental health topics including resilience, stress management, relationships and mindfulness, and resources including e-books, videos and guided meditations. Online discussion groups will foster awareness for specific issues and allow casual discussion. A curated collection of links to additional resources including the Solving Healthcare podcast will also be provided.
Study NCT04689750 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Next generation sequencing
Description: Genetic profile of donors will be collected at the time of PBSC or BM stem cell donation. Genetic profile of recipients will be collected at 1-month, 6-month, 12-month post-HSCT and at time of relapse or occurrence of leukaemia.~Gene mutations and pathogenic gene fusion will be determined in the peripheral blood and/or marrow samples by next-generation sequencing (NGS) using a myeloid-gene panel and nanopore long-read sequencing.
Study NCT05115279 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: breast conservative surgery for post chemotherapy tumour size
Description: * Skin preparation by povidine iodine.~* Excision of the mass with safety margin.~* Sentinel axillary lymph node or complete axillary clearance depend on axillary lymph node status~* All specimens were oriented with sutures~* A frozen section examination of the specimen was performed intraoperative~* When the margin status was inadequate, a re-excision was performed~* Closure as drawn by different oncoplastic technique
Study NCT04898374 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabin/cisplatin
Description: chemotherapy combination
Study NCT04898374 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabin/cisplatin
Description: chemotherapy combination
Study NCT05315401 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic
Description: This project aims to evaluate the efficacy of oral administration of probiotic at 9 log CFU/day as adjunctive treatment in reducing the severity depression in female patients with major depressive disorder with treatment-as-usual compared to placebo and ACT via use of questionnaires.
Study NCT05315401 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: This project aims to evaluate the efficacy of oral administration of probiotic at 9 log CFU/day as adjunctive treatment in reducing the severity depression in female patients with major depressive disorder with treatment-as-usual compared to placebo and ACT via use of questionnaires.
Study NCT05315401 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and commitment therapy (ACT)
Description: Patients will be provided with ACT for 12 weeks with treatment as usual. The ACT intervention will be conducted in a group of 10 for each session. The ACT modules covered over 12 sessions, 1 hour in each session. The sessions will be held every week.
Study NCT05563246 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3473329
Description: Administered orally
Study NCT06186232 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: guided bone regeneration (GBR).
Description: guided bone regeneration (GBR) using polymethylmethacrylate (PMMA) polymer as membrane.
Study NCT04547556 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: BioFire
Description: A molecular rapid syndromic testing platform, using the following panels:~* BioFire FilmArray Respiratory Panel 2.1 plus (RP2.1plus)~* BioFire FilmArray Pneumonia Panel plus (PP)
Study NCT06411938 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self-collection of vaginal swabs
Description: Women will collect vaginal swabs for HPV testing, then undergo standard of care screening for cervical cancer
Study NCT05689021 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abiraterone Acetate/Niraparib
Description: Given PO
Study NCT05563246 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered orally
Study NCT04922658 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Surufatinib
Description: Surufatinib,300mg, qd, po, 21 days for a cycle; continuous administration until PD, death or intolerable toxicity.
Study NCT04922658 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Surufatinib Plus Vinorelbine
Description: Surufatinib, 250mg, qd, po; Plus Vinorelbine, 20 mg, every 2 days; 21days for a cycle; continuous administration until PD, death or intolerable toxicity.
Study NCT05689021 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood specimen collection
Study NCT05689021 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo technetium-99m bone scan
Study NCT05689021 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT scan
Study NCT05689021 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT05689021 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Given PO
Study NCT05608018 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Intervention Bluetooth
Description: Participants will receive a Bluetooth device to use for the duration of the study, and will use the app with all features turned on.
Study NCT05608018 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Intervention non-Bluetooth
Description: Participants will not receive a Bluetooth device, and will use the app with all features turned on.
Study NCT05415046 — intervention group
Intervention type: PROCEDURE
Intervention: Sacral ESPB
Description: Erector spinae plane block performed with 0,25% bupivacaine (1 mL/kg-max 20mL), under general anesthesia before the start of the surgery.
Study NCT05608018 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control Bluetooth
Description: Participants will receive a Bluetooth device to use for the duration of the study, and will use the app with some features turned off.
Study NCT05608018 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control non-Bluetooth
Description: Participants will not receive a Bluetooth device, and will use the app with some features turned off.
Study NCT06471829 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lu AG13909
Description: Solution for injection/infusion
Study NCT05061953 — intervention group
Intervention type: DEVICE
Intervention: Eye-Tracking
Description: Eye-tracking technology and algorithms used to successfully capture and track eye movements using an electronic tablet and the embedded camera of the device.
Study NCT06202599 — intervention group
Intervention type: DRUG
Intervention: Fruquintinib
Description: For patients with pulmonary metastasis only, we mostly gave them fruquintinib with 7 mg in adults and 3-5 mg in children (\<10 years) orally per day (5 days on and 2 days off). If patients were extrapulmonary metastasis, we usually used combinations with metronomic chemotherapy (2/3 or 3/5 or even 1/2 of the usual dose) or immunotherapy.
Study NCT04912570 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Manual Thrombus Aspiration
Description: Manual thrombus aspiration using one of the FDA approved aspirators will be done.
Study NCT05691660 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAS3731 Dose1
Description: Oral administration,1 day,QD
Study NCT05691660 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAS3731 Dose2
Description: Oral administration,7 days,QD
Study NCT06306183 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Acetaminophen and Vitamin C with Naproxen rescue
Description: 900 mg vitamin C taken orally twice a day (one in the morning and one in the evening) for a 7-day period after ED discharge for the treatment arm used in combination with extended-release acetaminophen 650 mg two pills every eight hours regularly.~Naproxen 500mg as rescue medication if still in pain 60 minutes after treatment with acetaminophen.
Study NCT06306183 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Acetaminophen and Placebo with Naproxen rescue
Description: Placebo taken orally twice a day (one in the morning and one in the evening) for a 7-day period after ED discharge for the treatment arm used in combination with extended-release acetaminophen 650 mg two pills every eight hours regularly.~Naproxen 500mg as rescue medication if still in pain 60 minutes after treatment with acetaminophen.
Study NCT05691660 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAS3731 Dose3
Description: Oral administration,7 days,BID
Study NCT05691660 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Oral administration, 1 day,QD
Study NCT05691660 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Oral administration, 7 days,QD
Study NCT05691660 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Oral administration, 7 days,BID
Study NCT04912570 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard PCI
Description: Standard PCI according to the most recent guidelines
Study NCT04898738 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Alcohol based hand sanitizer
Description: Provision of ABHS to randomly selected households
Study NCT06553989 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: osteopatic visceral mobilization
Description: a combination of breathing and visceral mobilizations
Study NCT06435260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab+chemotherapy
Description: Chemotherapy combined with ICIs was started 5-7 days after the completion of radiotherapy:~AG: intravenous nab-paclitaxel 125 mg/m2 and gemcitabine 1000mg/m2 d1,8, q3w, 4 cycles.~Camrelizumab: 200mg, iv, 30min, q3w, 4 cycles.
Study NCT06435260 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: hypofractionated radiotherapy
Description: Hypofractionated radiotherapy: pGTV:40Gy/5F, PTV≥25Gy/5F.
Study NCT05630404 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Surgical ESPB
Description: In group IE, transverse processes will be palpated before sewing the surgical incision by the surgery team. The local anesthetic solution will be administered after the needle contacts the transverse process and its location is confirmed by negative aspiration. Once the needle tip will be placed within the interfacial plane and after careful aspiration to rule out intravascular needle placement, 5 mL of solution will be injected the proper injection site. Local anesthetic solution will be injected at 4 levels along the surgical incision line. A dose of 0.25% bupivacaine 20 mL will be injected in each side (total 40 mL).~Tenoxicam 20 mg and a dose of 100 mg tramadol intravenously will be performed to all patients 30 min before the end of the surgery for postoperative analgesia.
Study NCT05630404 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: US guided ESPB
Description: US guided ESP block will be performed. US probe will be placed longitudinally 2-3 cm lateral to the L3 transverse process. Erector spinae muscle will be visualized on the hyperechoic transverse process. The block needle will be inserted cranio caudal direction and then for correction of the needle 2 ml saline will be enjected deep into the erector spina muscle fascia. Following confirmation of the correct position of the needle 20 ml %0.25 bupivacaine will be administered for block in each side (total 40 mL).~Tenoxicam 20 mg and a dose of 100 mg tramadol intravenously will be performed to all patients 30 min before the end of the surgery for postoperative analgesia.
Study NCT04716192 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Positional release technique
Description: Positional Release Technique The subject lies supine with therapist standing on the affected side; tender points are located along the upper fibres of the trapezius. Pressure will applied by pinching the muscle between the thumb and fingers. The subject's head is laterally flexed toward the side of tender point, then therapist grasps the subject's forearm and abducts shoulder to approximately 90° a slight flexion or extension is added to obtain fine-tune. The ideal position of comfort achieved is held for a period of 90 seconds and followed by a passive return of the body part to an anatomically neutral position continued for 5 minutes.~Mayofascial Release Technique Therapeutic Ultrasound
Study NCT04716192 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Myofascial release technique & Ultrasound
Description: Myofascial Release Technique~* Position of the patient - sitting comfortably with supported back, elbow flexed with forearm placed on a pillow. A low load, long duration stretch is applied along the lines of maximal fascial restrictions. The fascia is palpated and the pressure is applied directly to the skin, into the direction of restriction just until resistance (tissue barrier) is felt. The pressure will be applied for 90 to120 seconds. This procedure will carried out without sliding over the skin or forcing the tissue until the fascia complex starts to yield and a sensation of softening is achieved.~* Therapeutic ultrasound with the frequency of 3Mhz , with continuous mode and an intensity of 0.1-1.5 W/cm2 for a duration of 5 min will given with the patient position back rest.